Inspire Investing’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$658K Sell
6,136
-57,946
-90% -$3.8M 0.03% 908
2026
Q1
$507K Buy
64,082
+36,245
+130% +$586K 0.03% 829
2025
Q4
$479K Buy
27,837
+10,729
+63% +$208K 0.04% 329
2025
Q3
$441K Buy
17,108
+10,438
+156% +$394K 0.04% 736
2025
Q2
$384K Buy
6,670
+3,537
+113% +$284K 0.04% 711
2025
Q1
$339K Sell
3,133
-5,569
-64% -$485K 0.04% 706
2024
Q4
$413K Buy
8,702
+4,490
+107% +$271K 0.05% 353
2024
Q3
$414K Buy
+4,212
New +$544K 0.04% 453

Other funds holding AGL

Inspire Investing's AGL Position: Q2 2026 in Review

Inspire Investing reduced its Agilon Health (AGL) stake by 90% in Q2 2026, selling an estimated $3.8M and leaving 6,136 shares worth $658K. The position accounts for 0.03% of the portfolio, ranked #908.

Inspire Investing first reported a position in AGL in Q3 2024 and has held it in 8 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Inspire Investing held 6,136 shares of Agilon Health worth $658K as of Q2 2026.
  • Inspire Investing sold 57,946 Agilon Health shares in Q2 2026, an estimated $3.8M.
  • Agilon Health made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #908 holding.
  • Inspire Investing first reported a position in Agilon Health in Q3 2024 and has held it in 8 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.